Generous gifts from Anne Laflamme and George and Theresa Gee endow Ella McKeirnan Memorial Fellowship at Notre Dame’s Harper Cancer Research Institute

Author: Erin Fennessy Lawlor

Man in green suit and hat, woman in blue jacket and Seahawks hat, and Ella McKeirnan logo.
Ella McKeirnan, right, with the Notre Dame leprechaun at Notre Dame Stadium.

With two generous gifts to the University of Notre Dame totaling $1 million, Anne Laflamme and George and Theresa Gee have established the Ella McKeirnan Memorial Endowment. The endowment—funded through $500,000 from Laflamme and $500,000 from the Gees—will permanently support the Ella McKeirnan Memorial Fellowship within the Harper Cancer Research Institute’s (HCRI) Research Cures Cancer Corps.

The Ella McKeirnan Memorial Fellowship was created in 2024 to honor the memory of Ella McKeirnan of Spokane, Washington, who died shortly before her 21st birthday in 2020 after being diagnosed with Ewing’s sarcoma, a rare form of bone cancer. The program,which welcomes a cohort of high school students to Notre Dame’s campus each summer to participate in cancer research at HCRI, honors Ella’s resilience, academic excellence, and desire to make a positive impact.

As a part of the Research Cures Cancer Corps (RC3) at Notre Dame, the fellowship addresses a critical challenge in the field of oncology: building a broader pipeline to careers in cancer research, an effort essential for advancing disease detection, prevention, and effective treatments for all populations.

“RC3 was founded on the belief that solving cancer’s greatest challenges requires inspiring and training the next generation of scientists as early as possible, and we are profoundly grateful to Anne Laflamme and to George and Theresa Gee for their extraordinary generosity in supporting this vision,” said M. Sharon Stack, the Ann F. Dunne and Elizabeth Riley Director of Harper Cancer Research Institute and Kleiderer-Pezold Professor of Chemistry & Biochemistry.

Ten students stand in front of the Main Building at the University of Notre Dame.
Members of the summer 2026 cohort of Ella McKeirnan Memorial Fellowship.

The fellowship, now supported by the endowment, gives high school sophomores and juniors from Spokane, Washington, and Coeur d'Alene, Idaho, the opportunity to spend eight weeks during the summer conducting hands-on cancer research under the guidance of Notre Dame faculty and research mentors. Each scholar receives a $5,000 stipend, roundtrip travel, and full room and board on campus, along with participation in scientific workshops, professional development, and enrichment activities.

“With more than 18 million Americans living with a history of cancer—a number that is projected to exceed 22 million by 2035—strengthening our national research workforce is a vital imperative,” said Jeffrey F. Rhoads, the John and Catherine Martin Family Vice President for Research and professor in the Department of Aerospace and Mechanical Engineering. “Investing in early-stage oncology career development ensures we build a resilient, highly skilled scientific pipeline capable of transforming cancer diagnostics, prevention, treatment, and long-term care."

Since welcoming its first cohort in the summer of 2024, the fellowship has provided 21 students with an immersive summer research experience. All eight program alumni who have reached college age are enrolled in college. Of those eight, five are pursuing STEM-related majors and two are first-generation college students.

“‘Research cures cancer’ is hard to argue with, but building the next generation of researchers is less than straightforward,” said Laflamme. “I have been so impressed with the students’ experiences in the first three cohorts of the fellowship and I’m honored to take part in the effort to make this program permanent.”

Two students in lab coats and gloves work at a counter with vials and pipettes.
Kingsley Ugorji, a member of the fellowship's summer 2026 cohort from Spokane, WA.

“Ella McKeirnan was, and remains, a force of good in this world,” said George and Theresa Gee. “She lost her battle to cancer but her memory lives on, and it is in her honor that we champion the Ella McKeirnan Memorial Endowment. There is no better place for this important research program than Notre Dame, a higher education powerhouse that strives to better the world for us all.”

Laflamme is a 1987 Notre Dame graduate residing in Spokane, Washington. The Gees are Notre Dame parents based in Post Falls, Idaho; their son Ryan, class of 1998, along with the Community Cancer Fund, supported the initial launch of the Ella McKeirnan Memorial Fellowship in 2024.

“It’s my hope that participants become a ‘force for good’ no matter where their careers take them,” Laflamme added.


Applications for the upcoming cycle of the Ella McKeirnan Memorial Fellowship are now open and will close on January 6, 2027, with the summer cohort scheduled from June 7 to July 30, 2027.

To learn more about the fellowship and other RC3 programs, including application information, please visit the HCRI website.

About the Harper Cancer Research Institute

Located in South Bend, Indiana, HCRI researchers are dedicated to conducting innovative and integrative research that confronts the complex challenges of cancer. From common malignancies to rare and recalcitrant cancers, researchers at the University of Notre Dame are united in multi-disciplinary teams with a common goal: to increase the survival of all patients diagnosed with cancer.

Contact

Khoa Huynh / Institute Programs Director

Harper Cancer Research Institute / University of Notre Dame

khuynh@nd.edu / +1 574-631-7818 / harpercancer.nd.edu

About Notre Dame Research

The University of Notre Dame is a leading global Catholic research university located in South Bend, Indiana (USA). Inspired by its Catholic mission and founder Rev. Edward Sorin, C.S.C.’s vision for the University to be “one of the most powerful means for doing good” in the world, Notre Dame’s faculty and students pursue globally significant research, scholarship, and creative endeavor that advances discovery, fosters innovation, and drives lasting positive impact. For more information, please visit NDR's website or NDR's LinkedIn.

Originally published by Erin Fennessy Lawlor at harpercancer.nd.edu on October 23, 2026.